See stock splits, reverse splits, mergers and other announced capital actions with effective dates.
Choose today, tomorrow, the next 7 or 30 days. Every event keeps its announced local time and direct source link.
Shares from the 1,000% bonus capital increase will be credited on 31 August, following the 27 August ex-rights date and 28 August record date. The company's capital will rise from TRY 58 million to TRY 638 million.
Offerpad Solutions will transfer from the NYSE to the Nasdaq Capital Market and retain the OPAD ticker. Nasdaq quote and trade feeds will begin carrying the security during pre-market hours.
Change Agents shares will begin trading on a 1-for-20 reverse-split basis, with a corresponding CUSIP change.
The Weatherford merger closed before the market opened on 1 September. NCSM shares were halted after the 31 August session, remained halted on 1 September and will be suspended from Nasdaq effective 2 September.
Veea shares will begin trading on a 1-for-20 reverse-split basis, with a corresponding CUSIP change.
Artelo Biosciences shares will begin trading on a 1-for-9 reverse-split basis, with a corresponding CUSIP change.
Valion Bio shares will begin trading on a 1-for-25 reverse-split basis, with a corresponding CUSIP change.
GlucoTrack shares will begin trading on a 1-for-15 reverse-split basis, with a corresponding CUSIP change.
Future FinTech Group shares will begin trading on a 1-for-4 reverse-split basis, with a corresponding CUSIP change.
Ohmyhome Class A shares will begin trading on a 1-for-50 reverse-split basis alongside a par-value and CUSIP change.
CalciMedica shares will begin trading on a 1-for-5 reverse-split basis, with a corresponding CUSIP change.
Founder Group Class A shares will begin trading on a 1-for-100 reverse-split basis, with a corresponding CUSIP change.
ENvue Medical shares will begin trading on a 1-for-12 reverse-split basis, with a corresponding CUSIP change.
NewGenIvf Group's Class A shares will begin trading on a 1-for-3 reverse-split basis, with a corresponding CUSIP change.
Lucas GC shares will begin trading on a 1-for-125 reverse-split basis alongside a par-value change and a new CUSIP number.
NorthStrive Acquisition unit holders may elect to separately trade the Class A shares, rights and warrants included in their units from 2 September. The new Nasdaq symbols are NSAI, NSAIR and NSAIW, respectively; unseparated units will continue trading as NSAIU.
Three Lions Acquisition completed its offering of 10 million units at $10 per unit for $100 million in gross proceeds. Each TLACU unit contains one ordinary share and one-half warrant, and the units are trading on Nasdaq.
Amphenol will distribute one additional share for every share held at the 17 August record-date close. The 2-for-1 split doubles the share count without changing an investor's proportional ownership.
FBS Global set 5:00 PM ET on 2 September as the record date for shareholders entitled to vote at the 13 September extraordinary meeting on the proposed 1-for-10 share consolidation. This is not the consolidation's effective date.
The Vertex merger closed before the market opened on 1 September. CRNX shares remained halted on 1 September and will be suspended from Nasdaq effective 2 September. The merger consideration is $85 in cash per share.
2 September was the final trading day for Apogee Therapeutics shares; APGE trading was halted at about 7:50 PM ET after hours. The AbbVie merger consideration is $135.11 in cash per share.
LivePerson shareholders approved the merger with SoundHound AI on 2 September. Each LPSN share will receive 0.4673 SoundHound AI shares.
USA Rare Earth completed its combination with Serra Verde Group on 3 September. The Nasdaq-listed company, trading as USAR, now combines rare-earth and magnet assets in the United States, Brazil and the United Kingdom.
The business combination of JFB Construction and XTEND closed after the market close on 3 September, which became JFB's final Nasdaq trading day. Each JFB share will receive one share of Xtend AI Robotics (XTND).
Türkiye's Capital Markets Board approved Global Endüstriyel Yatırımlar' IPO prospectus, covering a TRY 62.5 million capital increase and TRY 25 million nominal sale by existing shareholders. The fixed price is TRY 25.52 per TRY 1 nominal share; the decision does not specify book-building or trading dates.
Lianhe Sowell's follow-on offering of 7,638,889 units at $1.44 per unit is expected to close on 3 September for approximately $11 million in gross proceeds, subject to customary closing conditions.
Tantech Holdings' reverse split, combining every 50 Class A ordinary shares into one share, becomes effective at 4:01 p.m. ET on 3 September; split-adjusted trading begins on 4 September.
The Apogee Therapeutics–AbbVie merger closed before the market opened on 3 September. Apogee shareholders will receive $135.11 in cash per share.
3 September was the final trading day for LivePerson shares; LPSN trading was halted at about 7:50 PM ET after hours. Each LPSN share will receive 0.4673 SOUN shares.
Following completion of the XTEND combination, Nasdaq trading in JFB shares will be suspended on 4 September. The combined company is expected to list on the NYSE as Xtend AI Robotics under XTND; Nasdaq's notice does not provide a separate NYSE trading-start date.
CollPlant will consolidate its ordinary shares on a 1-for-10 basis, and CLGN shares will begin split-adjusted trading when Nasdaq opens on 4 September. Fractional shares will be rounded to the nearest whole share, and the ticker will remain unchanged.
Tantech Holdings shares will begin split-adjusted trading after the 1-for-50 reverse split under the unchanged TANH symbol and a new CUSIP number.
In the distribution connected with the Korsana Biosciences business combination, holders of record on 4 September will receive one contingent value right (CVR) for each CYCN share. Nasdaq will not quote the shares ex-distribution; the payment date has not been announced.
Following completion of the AbbVie merger, APGE trading was suspended from Nasdaq effective at the 4 September market open.
The LivePerson–SoundHound AI merger closed before the market opened on 4 September. Each LPSN share will receive 0.4673 SOUN shares.
DeFi Development Corp. priced 1,375,000 shares of its Variable Rate Series C Perpetual Preferred Stock at $8 per share. Settlement and closing of the approximately $11 million CHAD offering are scheduled for 8 September, subject to customary closing conditions.
AtaiBeckley shareholders will vote on the proposed merger with Eli Lilly on 8 September. If approved and completed as anticipated, 8 September will be ATAI's final trading day and the shares will be halted after hours at about 7:50 PM ET. The merger consideration is $6.75 in cash plus one contingent value right per share.
CytoSorbents common stock will undergo a 1-for-20 reverse split effective 8 September. The CTSO ticker will remain unchanged and the new CUSIP will be 23283X305.
Megan Holdings Class A ordinary shares will undergo a 1-for-40 reverse split effective 8 September. The MGN ticker will remain unchanged and the new CUSIP will be G5980E113.
La Rosa Holdings common stock will undergo a 1-for-6 reverse split effective 8 September. The LRHC ticker will remain unchanged and the new CUSIP will be 50172T509.
GT Biopharma common stock will undergo a 1-for-25 reverse split effective 8 September. The GTBP ticker will remain unchanged and the new CUSIP will be 36254L407.
Xiao-I ADSs will undergo a 1-for-7 reverse split effective 8 September. Each ADS will represent 420 ordinary shares instead of 60, while the AIXI ticker will remain unchanged.
TNL Mediagene ordinary shares will undergo a 1-for-8 reverse split effective 8 September, with par value changing from $0.002 to $0.016. The TNMG ticker will remain unchanged.
Wellchange Holdings Class A shares will undergo a 1-for-5 reverse split effective 8 September, with par value changing from $0.000005 to $0.000025. The WCT ticker will remain unchanged.
Shengfeng Development will consolidate its Class A and Class B shares on a 1-for-15 basis; SFWL shares are expected to begin post-split trading on Nasdaq at the market open on 8 September. Fractional shares will be rounded up to the nearest whole share.
The business combination between Cyclerion Therapeutics and Korsana Biosciences is expected to close on 8 September, subject to satisfaction of the closing conditions. Nasdaq also confirmed the distribution of one CVR for each CYCN share held on the 4 September record date.
Following completion of the merger, LPSN trading will be suspended from Nasdaq effective at the 8 September market open.
The 21Shares 2x Long Dogecoin ETF reverse split, combining every 10 TXXD shares into one, becomes effective on 8 September. The ticker will remain unchanged and the CUSIP will change to 53656H553.
Alpha Compute ordinary shares will undergo a 1-for-50 reverse split effective 9 September. The ALP ticker will remain unchanged and the new CUSIP will be G7185A144.
Subject to shareholder approval and the other closing conditions, the AtaiBeckley–Eli Lilly merger is expected to close before the market opens on 9 September. ATAI shares are expected to remain halted throughout the closing day.
If the combination closes as anticipated, Cyclerion shares will complete a 1-for-7 reverse split on 9 September; the company name will become Korsana Biosciences, Inc., the Nasdaq symbol will change to KRSA and the new CUSIP will be 23255M303.
U Power Limited's Class A ordinary shares will effect a 1-for-20 reverse split on 9 September. Par value will change from $0.0001 to $0.002 and the CUSIP will change to G9520U132; the UCAR symbol will remain unchanged.
If the merger closes as anticipated, ATAI trading is expected to be suspended from Nasdaq effective 10 September. Holders will receive $6.75 in cash plus one contingent value right for each share.
Skyworks extended the expiration of its exchange offers for Qorvo's senior notes due 2029 and 2031 from 1 September to 5:00 PM ET on 11 September; all other terms remain unchanged.
BiomX will change its name to Tessera Defense and Homeland Security, and its shares will trade on NYSE American under HLSQ. No shareholder action is required.
FBS Global shareholders will vote on a fixed 1-for-10 share consolidation proposed to support compliance with Nasdaq's $1 minimum bid-price rule. Implementation remains subject to shareholder approval and Nasdaq clearance; the post-consolidation trading date has not been announced.
Brookfield will redeem all Series 51 shares on 1 November for C$22.44 per share plus accrued dividends and all Series 52 shares for C$22.00 per share. The final Series 52 dividend has a 15 October record date and 30 October payment date.
Kyivstar rescheduled its Capital Markets Day to 17 November. Management will discuss strategic priorities, business performance and outlook; attendance and webcast timing will be announced later.